[Federal Register Volume 88, Number 139 (Friday, July 21, 2023)]
[Notices]
[Page 47151]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-15456]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket Nos. FDA-2018-D-4417, FDA-2013-N-1619, FDA-2018-D-2613, FDA-
2021-N-0341, FDA-2016-N-2066, FDA-2022-N-0862, and FDA-2022-N-1874]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approvals

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is publishing a list of 
information collections that have been approved by the Office of 
Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: JonnaLynn Capezzuto, Office of 
Operations, Food and Drug Administration, Three White Flint North, 10A-
12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-3794, 
[email protected].

SUPPLEMENTARY INFORMATION: The following is a list of FDA information 
collections recently approved by OMB under section 3507 of the 
Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control 
number and expiration date of OMB approval for each information 
collection are shown in table 1. Copies of the supporting statements 
for the information collections are available on the internet at 
https://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or 
sponsor, and a person is not required to respond to, a collection of 
information unless it displays a currently valid OMB control number.

        Table 1--List of Information Collections Approved by OMB
------------------------------------------------------------------------
                                            OMB control    Date approval
           Title of collection                  No.           expires
------------------------------------------------------------------------
Current Good Manufacturing Practice            0910-0139       6/30/2026
 (CGMP): Manufacturing, Processing,
 Packing, and Holding of Drugs; GMP for
 Finished Pharmaceuticals (Including
 Medical Gases and Active Pharmaceutical
 Ingredients)...........................
Current Good Manufacturing Practice in         0910-0606       6/30/2026
 Manufacturing, Packaging, Labeling, or
 Holding Operations for Dietary
 Supplements............................
Prescription Drug Advertisements........       0910-0686       6/30/2026
Federal-State Food Regulatory Program          0910-0760       6/30/2026
 Standards..............................
Certification of Identity for Freedom of       0910-0832       6/30/2026
 Information and Privacy Act Requests...
The Real Cost Campaign Outcomes                0910-0915       6/30/2026
 Evaluation Study: Cohort 3 (Outcomes
 Study).................................
Perceptions of Prescription Drug               0910-0916       6/30/2026
 Products with Medication Tracking
 Capabilities...........................
------------------------------------------------------------------------


    Dated: July 17, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023-15456 Filed 7-20-23; 8:45 am]
BILLING CODE 4164-01-P


